Cervical specimen positive for HPV-16 and/or HPV-18 DNA using the Digene Hybrid Capture® II HPV test within 21 days of study entry [clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf]

Cervical specimen positive for HPV-16 and/or HPV-18 DNA using the Digene Hybrid Capture® II HPV test within 21 days of study entry [clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf

Cervical specimen positive for HPV-16 and/or HPV-18 DNA using the Digene Hybrid Capture® II HPV test within 21 days of study entry [clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf
Bio2RDF identifier
cba7a940fa476f7a5c7896dbc9993dcf
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf
identifier
clinicaltrials_resource:cba7a940fa476f7a5c7896dbc9993dcf
title
Cervical specimen positive for ...... within 21 days of study entry
@en
inDataset
type
label
Cervical specimen positive for ...... 7a940fa476f7a5c7896dbc9993dcf]
@en